Cargando…
Efficient In Vivo Liver-Directed Gene Editing Using CRISPR/Cas9
In vivo tissue-specific genome editing at the desired loci is still a challenge. Here, we report that AAV9-delivery of truncated guide RNAs (gRNAs) and Cas9 under the control of a computationally designed hepatocyte-specific promoter lead to liver-specific and sequence-specific targeting in the mous...
Autores principales: | Singh, Kshitiz, Evens, Hanneke, Nair, Nisha, Rincón, Melvin Y., Sarcar, Shilpita, Samara-Kuko, Ermira, Chuah, Marinee K., VandenDriessche, Thierry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993986/ https://www.ncbi.nlm.nih.gov/pubmed/29599079 http://dx.doi.org/10.1016/j.ymthe.2018.02.023 |
Ejemplares similares
-
Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy
por: Tipanee, Jaitip, et al.
Publicado: (2022) -
Genome-wide Computational Analysis Reveals Cardiomyocyte-specific Transcriptional Cis-regulatory Motifs That Enable Efficient Cardiac Gene Therapy
por: Rincon, Melvin Y, et al.
Publicado: (2015) -
Comprehensive transcriptome-wide analysis of spliceopathy correction of myotonic dystrophy using CRISPR-Cas9 in iPSCs-derived cardiomyocytes
por: Dastidar, Sumitava, et al.
Publicado: (2022) -
Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation
por: Rincon, Melvin Y., et al.
Publicado: (2015) -
Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons
por: Tipanee, Jaitip, et al.
Publicado: (2020)